The MEK inhibitors: trametinib and selumetinib

Understanding Childhood Cancer With Dr Geoff by Dr Geoff

Feb 19, 202141:14Science & Medicine

The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis. Hosted on Acast...

Related Episodes

Continue listening to more episodes from Understanding Childhood Cancer With Dr Geoff.

CAR T-cells, Interview with Dr Caroline Bateman

Mar 14, 2022 - 45:55

CAR T-cell therapy is an exciting new treatment for acute leukaemia. In this episode, Dr Geoff interviews...

"S" is for "Special" : Stage MS Neuroblastoma (also called Stage IVS, 4S)

May 20, 2021 - 24:26

There is a special subtype of neuroblastoma seen in very young children, with spread of disease throughou...

Where did my child's immune system go?

Mar 26, 2021 - 44:44

Childhood cancer treatment leads to severe impairment of the ability to fight infections. This episode ex...

Update re the future of rock and roll.... CAR T-cells

Mar 10, 2021 - 39:46

A few years ago I described CAR T-cells, but they weren't available for routine use. I now update things,...

Blood Cultures

Mar 8, 2021 - 22:13

We take a lot of blood samples looking for infection in the bloodstream. This episode explains what blood...

PRISM, Molecular Profiling, and Informed Consent

Feb 24, 2021 - 56:12

A number of countries have research studies where childhood cancers are analysed in great detail, testing...

The needle in the haystack: Minimal Residual Disease

Jan 14, 2021 - 42:05

Sophisticated techniques can detect one cancer cell amongst a million normal cells. This episode describe...

DIPG: to biopsy or not to biopsy

Nov 16, 2020 - 13:37

For many years we didn't biopsy the tumour when the scans suggested that the tumour was a DIPG. This epis...